We invite you to participate in the section “Epidemiological surveillance of current infections: new threats and challenges.”
05  10.2026
The session will take place on October 29, 2026, as part of the 14th Interregional Interdisciplinary Scientific and Practical Conference "Current Infectious Diseases of the Volga-Vyatka Region."
Educators in the Nizhny Novgorod region were briefed on the prevention of infectious diseases
25  09.2026
On September 25, 2026, two online seminars were held for educators from the Nizhny Novgorod region.

Laboratory of Immunochemistry

Home  »  Structure  »  Laboratories  »  Laboratory of Immunochemistry
Print version

Head of the laboratory – Honored Scientist of the Russian Federation, Doctor of Biological Sciences (DSc. in Biology), Professor

Viktor V. Novikov

The laboratory of biochemistry was organized in 1969.Research was aimed at studying the structure and function of serum proteins in order to develop therapeutic and prophylactic blood products, as well as at studying the immunological properties of various classes of immunoglobulins. 

Directions of activities:

  • Development of immunoglobulin preparations suitable for intravenous administration and study of physicochemical and biological properties, as well as improvement of the quality of existing and developed preparations.

  • Development of diagnostic preparations and test systems for quantitative determination of human serum proteins.

  • Study of the role of infectious agents - pathogens of gastroenterological pathology - in the development of local and systemic shifts in autoimmune homeostasis.

  • Development of a new generation of genetically engineered vaccines for the prevention of viral infections.

    Laboratory achievements:
  • An industrial method has been developed for obtaining the first immunoglobulin preparation in the USSR for intravenous administration. Developers headed by Academician of the Academy of Medical Sciences of the USSR I.N. Blokhinawere awarded the USSR State Prize.
  • An experimental laboratory technology for obtaining the medicinal preparation ceruloplasmin has been developed.
  • Experimental test systems have been developed to determine a wide range of autoantibodies and serum proteins.
  • A new molecular platform has been developed for obtaining antiviral vaccines based on virus-like particles of norovirus and chimeric recombinant proteins.
  • Prototypes of recombinant vaccines have been developed to prevent norovirus, coronavirus infections, and infections caused by the ECHO-30 virus.

Prospects:

  • In 2019 the researches on development of recombinant vaccine of new generation for prevention of an enteroviral infection are initiated.

Phone: +7(831) 469-79-56 Victor V. Novikov

                          469-79-55 general issues

E-mail: lab.imchem@nniiem.ru

Address: 603022, Nizhny Novgorod, Malaya Yamskaya st., 71, 7th floor.

Go to the top